{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T02:59:40Z","timestamp":1784948380775,"version":"3.55.0"},"reference-count":45,"publisher":"The Endocrine Society","issue":"4","license":[{"start":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T00:00:00Z","timestamp":1727913600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100020595","name":"National Science and Technology Council of Taiwan","doi-asserted-by":"publisher","award":["NSTC-110-2314-B-195-018-MY3"],"award-info":[{"award-number":["NSTC-110-2314-B-195-018-MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council of Taiwan","doi-asserted-by":"publisher","award":["NSTC-113-2314-B-195-015"],"award-info":[{"award-number":["NSTC-113-2314-B-195-015"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004861","name":"MacKay Memorial Hospital","doi-asserted-by":"publisher","award":["MMH-11314"],"award-info":[{"award-number":["MMH-11314"]}],"id":[{"id":"10.13039\/501100004861","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004861","name":"MacKay Memorial Hospital","doi-asserted-by":"publisher","award":["MMH-E-113-08"],"award-info":[{"award-number":["MMH-E-113-08"]}],"id":[{"id":"10.13039\/501100004861","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,17]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Context<\/jats:title>\n                  <jats:p>Dysregulation of circadian rhythms has been linked to cancer susceptibility. Thyroid cancer cells demonstrate altered circadian oscillations in endogenous clock transcripts.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>Our previous research identified NR1D1, a component of the circadian clock, as one of the recurrence-associated genes in papillary thyroid cancer. The objective of this study was to investigate the expression pattern of NR1D1 in thyroid cancer and explore its prognostic and translational implications.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We assessed NR1D1 expression using immunohistochemical analysis and examined its correlation with clinicopathological parameters. In vitro and in vivo experiments were performed to elucidate the oncogenic roles of NR1D1 and potential mechanisms.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Nuclear NR1D1 expression was present in thyroid follicular epithelial-derived cancers, whereas normal thyroid tissue and benign nodular goiter showed no detectable NR1D1 immunoreactivity. Patients with high expression of NR1D1 had more advanced disease stages, extrathyroidal extension, lymphovascular invasion, and shorter recurrence-free survival compared to those with low levels of NR1D1. Through gain- and loss-of-function studies, we demonstrated that NR1D1 modulation affected the growth of organoids, resistance to anoikis, and the invasive and migratory capacity of thyroid cancer cells. The invasion-promoting effect of NR1D1 was regulated by the \u03b2-catenin\/ZEB1 axis. Moreover, the overexpression of NR1D1 accelerated xenograft growth and lung metastasis in vivo.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>NR1D1 is overexpressed in malignant thyroid tumors and has prognostic significance. Our findings suggest therapeutic potential in targeting NR1D1 for thyroid cancer.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/clinem\/dgae687","type":"journal-article","created":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T06:50:42Z","timestamp":1727938242000},"page":"991-1002","source":"Crossref","is-referenced-by-count":13,"title":["Overexpression of NR1D1 Portends Disease Recurrence in Thyroid Cancer"],"prefix":"10.1210","volume":"110","author":[{"given":"Yi-Chiung","family":"Hsu","sequence":"first","affiliation":[{"name":"Department of Biomedical Sciences and Engineering, National Central University , Taoyuan 320317 ,","place":["Taiwan"]},{"name":"Center for Astronautical Physics and Engineering, National Central University , Taoyuan 320317 ,","place":["Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Yu","family":"Kuo","sequence":"additional","affiliation":[{"name":"Department of Surgery, MacKay Memorial Hospital , Taipei 104217 ,","place":["Taiwan"]},{"name":"Department of Medicine, School of Medicine, MacKay Medical College , New Taipei City 252005 ,","place":["Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Nan","family":"Chien","sequence":"additional","affiliation":[{"name":"Department of Medicine, School of Medicine, MacKay Medical College , New Taipei City 252005 ,","place":["Taiwan"]},{"name":"Division of Endocrinology and Metabolism, Department of Internal Medicine, MacKay Memorial Hospital , Taipei 104217 ,","place":["Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie-Yang","family":"Jhuang","sequence":"additional","affiliation":[{"name":"Department of Medicine, School of Medicine, MacKay Medical College , New Taipei City 252005 ,","place":["Taiwan"]},{"name":"Department of Pathology, MacKay Memorial Hospital , Taipei 104217 ,","place":["Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Yuan","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Medical Research, MacKay Memorial Hospital , Taipei 104217 ,","place":["Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-Chiang","family":"Chang","sequence":"additional","affiliation":[{"name":"Department of Medical Research, MacKay Memorial Hospital , Taipei 104217 ,","place":["Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6301-5096","authenticated-orcid":false,"given":"Shih-Ping","family":"Cheng","sequence":"additional","affiliation":[{"name":"Department of Surgery, MacKay Memorial Hospital , Taipei 104217 ,","place":["Taiwan"]},{"name":"Department of Medicine, School of Medicine, MacKay Medical College , New Taipei City 252005 ,","place":["Taiwan"]},{"name":"Department of Medical Research, MacKay Memorial Hospital , Taipei 104217 ,","place":["Taiwan"]},{"name":"Institute of Biomedical Sciences, MacKay Medical College , New Taipei City 252005 ,","place":["Taiwan"]},{"name":"Department of Pharmacology, School of Medicine, College of Medicine, Taipei Medical University , Taipei 110301 ,","place":["Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2024,10,3]]},"reference":[{"issue":"6","key":"2025031717031961500_dgae687-B1","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s10552-023-01694-y","article-title":"Trends in thyroid cancer burden in Taiwan over two decades","volume":"34","author":"Cheng","year":"2023","journal-title":"Cancer Causes Control"},{"issue":"1","key":"2025031717031961500_dgae687-B2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/JOM.0000000000001711","article-title":"Night shift working is associated with an increased risk of thyroid nodules","volume":"62","author":"Rizza","year":"2020","journal-title":"J Occup Environ Med"},{"issue":"23","key":"2025031717031961500_dgae687-B3","doi-asserted-by":"crossref","first-page":"5673","DOI":"10.3390\/cancers15235673","article-title":"Rotating night shift work, sleep, and thyroid cancer risk in the urses' health study 2","volume":"15","author":"Papantoniou","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"6","key":"2025031717031961500_dgae687-B4","doi-asserted-by":"crossref","first-page":"R305","DOI":"10.1530\/ERC-19-0094","article-title":"Clock genes and cancer development in particular in endocrine tissues","volume":"26","author":"Angelousi","year":"2019","journal-title":"Endocr Relat Cancer"},{"issue":"6","key":"2025031717031961500_dgae687-B5","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1056\/NEJMra1802337","article-title":"Circadian mechanisms in medicine","volume":"384","author":"Allada","year":"2021","journal-title":"N Engl J Med"},{"issue":"12","key":"2025031717031961500_dgae687-B6","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1038\/s41591-018-0271-8","article-title":"The emerging link between cancer, metabolism, and circadian rhythms","volume":"24","author":"Masri","year":"2018","journal-title":"Nat Med"},{"key":"2025031717031961500_dgae687-B7","doi-asserted-by":"crossref","first-page":"e4327","DOI":"10.7717\/peerj.4327","article-title":"Evidence for widespread dysregulation of circadian clock progression in human cancer","volume":"6","author":"Shilts","year":"2018","journal-title":"PeerJ"},{"issue":"3","key":"2025031717031961500_dgae687-B8","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.cels.2018.03.006","article-title":"Escaping circadian regulation: an emerging hallmark of cancer?","volume":"6","author":"El-Athman","year":"2018","journal-title":"Cell Syst"},{"issue":"11","key":"2025031717031961500_dgae687-B9","doi-asserted-by":"crossref","first-page":"4446","DOI":"10.1210\/jc.2013-2568","article-title":"Circadian clock characteristics are altered in human thyroid malignant nodules","volume":"98","author":"Mannic","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2025031717031961500_dgae687-B10","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1016\/j.surg.2016.12.039","article-title":"Recurrence-associated genes in papillary thyroid cancer: an analysis of data from the cancer genome atlas","volume":"161","author":"Chien","year":"2017","journal-title":"Surgery"},{"issue":"9","key":"2025031717031961500_dgae687-B11","doi-asserted-by":"crossref","first-page":"4168","DOI":"10.7150\/thno.43834","article-title":"Targeting REV-ERB\u03b1 for therapeutic purposes: promises and challenges","volume":"10","author":"Wang","year":"2020","journal-title":"Theranostics"},{"issue":"10","key":"2025031717031961500_dgae687-B12","doi-asserted-by":"crossref","first-page":"e37807","DOI":"10.1371\/journal.pone.0037807","article-title":"mRNA expression in papillary and anaplastic thyroid carcinoma: molecular anatomy of a killing switch","volume":"7","author":"Hebrant","year":"2012","journal-title":"PLoS One"},{"issue":"10","key":"2025031717031961500_dgae687-B13","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1038\/bjc.2014.665","article-title":"Revisiting the transcriptional analysis of primary tumours and associated nodal metastases with enhanced biological and statistical controls: application to thyroid cancer","volume":"112","author":"Tarabichi","year":"2015","journal-title":"Br J Cancer"},{"issue":"11","key":"2025031717031961500_dgae687-B14","doi-asserted-by":"crossref","first-page":"e169653","DOI":"10.1172\/JCI169653","article-title":"Anaplastic transformation in thyroid cancer revealed by single-cell transcriptomics","volume":"133","author":"Lu","year":"2023","journal-title":"J Clin Invest"},{"issue":"3","key":"2025031717031961500_dgae687-B15","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/his.12562","article-title":"Expression of haem oxygenase-1 correlates with tumour aggressiveness and BRAF V600E expression in thyroid cancer","volume":"66","author":"Wang","year":"2015","journal-title":"Histopathology"},{"issue":"1","key":"2025031717031961500_dgae687-B16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid"},{"issue":"4","key":"2025031717031961500_dgae687-B17","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s12022-019-09586-1","article-title":"Overexpression of histone H3 lysine 27 trimethylation is associated with aggressiveness and dedifferentiation of thyroid cancer","volume":"30","author":"Tsai","year":"2019","journal-title":"Endocr Pathol"},{"issue":"10","key":"2025031717031961500_dgae687-B18","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1158\/1078-0432.CCR-18-2953","article-title":"Comprehensive genetic characterization of human thyroid cancer cell lines: a validated panel for preclinical studies","volume":"25","author":"Landa","year":"2019","journal-title":"Clin Cancer Res"},{"issue":"12","key":"2025031717031961500_dgae687-B19","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1002\/mc.23626","article-title":"Downregulation of cellular retinoic acid binding protein 1 fosters epithelial-mesenchymal transition in thyroid cancer","volume":"62","author":"Hsu","year":"2023","journal-title":"Mol Carcinog"},{"key":"2025031717031961500_dgae687-B20","doi-asserted-by":"crossref","first-page":"1294760","DOI":"10.3389\/ftox.2023.1294760","article-title":"Acute exposure to diesel particulate matter promotes collective cell migration in thyroid cancer cells","volume":"5","author":"Cheng","year":"2023","journal-title":"Front Toxicol"},{"issue":"12","key":"2025031717031961500_dgae687-B21","doi-asserted-by":"crossref","first-page":"bqac171","DOI":"10.1210\/endocr\/bqac171","article-title":"CRABP2 is associated with thyroid cancer recurrence and promotes invasion via the integrin\/FAK\/AKT pathway","volume":"163","author":"Liu","year":"2022","journal-title":"Endocrinology"},{"issue":"2","key":"2025031717031961500_dgae687-B22","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/path.5503","article-title":"Overexpression of chitinase-3-like protein 1 is associated with structural recurrence in patients with differentiated thyroid cancer","volume":"252","author":"Cheng","year":"2020","journal-title":"J Pathol"},{"issue":"2","key":"2025031717031961500_dgae687-B23","doi-asserted-by":"crossref","first-page":"e0298903","DOI":"10.1371\/journal.pone.0298903","article-title":"Sublethal thermal stress promotes migration and invasion of thyroid cancer cells","volume":"19","author":"Kuo","year":"2024","journal-title":"PLoS One"},{"issue":"2","key":"2025031717031961500_dgae687-B24","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1530\/ERC-21-0256","article-title":"SREBP1 promotes invasive phenotypes by upregulating CYR61\/CTGF via the Hippo-YAP pathway","volume":"29","author":"Kuo","year":"2022","journal-title":"Endocr Relat Cancer"},{"key":"2025031717031961500_dgae687-B25","doi-asserted-by":"crossref","first-page":"112062","DOI":"10.1016\/j.mce.2023.112062","article-title":"SOX4 is a pivotal regulator of tumorigenesis in differentiated thyroid cancer","volume":"578","author":"Kuo","year":"2023","journal-title":"Mol Cell Endocrinol"},{"issue":"4","key":"2025031717031961500_dgae687-B26","first-page":"243","article-title":"Venetoclax-based regimen for elderly patients with acute myeloid leukemia: a real-world experience from a tertiary center in Taiwan","volume":"17","author":"Chen","year":"2023","journal-title":"Int J Gerontol"},{"issue":"1","key":"2025031717031961500_dgae687-B27","doi-asserted-by":"crossref","first-page":"2178659","DOI":"10.1080\/10641963.2023.2178659","article-title":"Nuclear receptor subfamily 1 group D member 1 suppresses the proliferation, migration of adventitial fibroblasts, and vascular intimal hyperplasia via mammalian target of rapamycin complex 1\/\u03b2-catenin pathway","volume":"45","author":"Peng","year":"2023","journal-title":"Clin Exp Hypertens"},{"issue":"2","key":"2025031717031961500_dgae687-B28","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/cdd.2013.123","article-title":"The EMT activator ZEB1 promotes tumor growth and determines differential response to chemotherapy in mantle cell lymphoma","volume":"21","author":"Sanchez-Tillo","year":"2014","journal-title":"Cell Death Differ"},{"issue":"3","key":"2025031717031961500_dgae687-B29","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1530\/JOE-17-0111","article-title":"Hypophysectomy abolishes rhythms in rat thyroid hormones but not in the thyroid clock","volume":"233","author":"Fahrenkrug","year":"2017","journal-title":"J Endocrinol"},{"issue":"10","key":"2025031717031961500_dgae687-B30","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/s41419-022-05342-2","article-title":"Loss of thyroid gland circadian PER2 rhythmicity in aged mice and its potential association with thyroid cancer development","volume":"13","author":"Lee","year":"2022","journal-title":"Cell Death Dis"},{"issue":"11","key":"2025031717031961500_dgae687-B31","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.3390\/cancers12113109","article-title":"Thyroid cancer and circadian clock disruption","volume":"12","author":"Malaguarnera","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"4","key":"2025031717031961500_dgae687-B32","doi-asserted-by":"crossref","first-page":"R95","DOI":"10.1530\/ERC-20-0475","article-title":"Cancer clocks in tumourigenesis: the p53 pathway and beyond","volume":"28","author":"Stephenson","year":"2021","journal-title":"Endocr Relat Cancer"},{"issue":"10","key":"2025031717031961500_dgae687-B33","doi-asserted-by":"crossref","first-page":"8980","DOI":"10.3390\/ijms24108980","article-title":"The role of REV-ERB receptors in cancer pathogenesis","volume":"24","author":"Gomatou","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"10","key":"2025031717031961500_dgae687-B34","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1080\/15592294.2021.2009997","article-title":"Exploring the impact of night shift work on methylation of circadian genes","volume":"17","author":"Ritonja","year":"2022","journal-title":"Epigenetics"},{"issue":"6","key":"2025031717031961500_dgae687-B35","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1089\/thy.2013.0509","article-title":"Nuclear receptor expression in human differentiated thyroid tumors","volume":"24","author":"Mond","year":"2014","journal-title":"Thyroid"},{"issue":"9","key":"2025031717031961500_dgae687-B36","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1158\/0008-5472.CAN-16-2099","article-title":"NR1D1 recruitment to sites of DNA damage inhibits repair and is associated with chemosensitivity of breast cancer","volume":"77","author":"Ka","year":"2017","journal-title":"Cancer Res"},{"issue":"4","key":"2025031717031961500_dgae687-B37","doi-asserted-by":"crossref","first-page":"853","DOI":"10.3390\/cancers12040853","article-title":"The core-clock gene NR1D1 impacts cell motility in vitro and invasiveness in a zebrafish xenograft colon cancer model","volume":"12","author":"Basti","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"7396","key":"2025031717031961500_dgae687-B38","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nature11030","article-title":"Regulation of circadian behaviour and metabolism by synthetic REV-ERB agonists","volume":"485","author":"Solt","year":"2012","journal-title":"Nature"},{"issue":"25","key":"2025031717031961500_dgae687-B39","doi-asserted-by":"crossref","first-page":"12147","DOI":"10.1073\/pnas.1904226116","article-title":"SR9009 has REV-ERB-independent effects on cell proliferation and metabolism","volume":"116","author":"Dierickx","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7688","key":"2025031717031961500_dgae687-B40","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/nature25170","article-title":"Pharmacological activation of REV-ERBs is lethal in cancer and oncogene-induced senescence","volume":"553","author":"Sulli","year":"2018","journal-title":"Nature"},{"issue":"7","key":"2025031717031961500_dgae687-B41","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/nrc.2017.32","article-title":"Common pitfalls in preclinical cancer target validation","volume":"17","author":"Kaelin","year":"2017","journal-title":"Nat Rev Cancer"},{"issue":"7","key":"2025031717031961500_dgae687-B42","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.tem.2019.05.001","article-title":"Circadian clocks and cancer: timekeeping governs cellular metabolism","volume":"30","author":"Verlande","year":"2019","journal-title":"Trends Endocrinol Metab"},{"issue":"3","key":"2025031717031961500_dgae687-B43","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0002-9440(10)64045-X","article-title":"Beta-catenin dysregulation in thyroid neoplasms: down-regulation, aberrant nuclear expression, and CTNNB1 exon 3 mutations are markers for aggressive tumor phenotypes and poor prognosis","volume":"158","author":"Garcia-Rostan","year":"2001","journal-title":"Am J Pathol"},{"issue":"48","key":"2025031717031961500_dgae687-B44","doi-asserted-by":"crossref","first-page":"19204","DOI":"10.1073\/pnas.1108977108","article-title":"\u03b2-catenin\/TCF4 complex induces the epithelial-to-mesenchymal transition (EMT)-activator ZEB1 to regulate tumor invasiveness","volume":"108","author":"Sanchez-Tillo","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"2025031717031961500_dgae687-B45","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1158\/0008-5472.CAN-17-2476","article-title":"Pleiotropic roles for ZEB1 in cancer","volume":"78","author":"Caramel","year":"2018","journal-title":"Cancer Res"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgae687\/59760981\/dgae687.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/110\/4\/991\/59760981\/dgae687.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/110\/4\/991\/59760981\/dgae687.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T17:03:44Z","timestamp":1742231024000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/110\/4\/991\/7808457"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,3]]},"references-count":45,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,10,3]]},"published-print":{"date-parts":[[2025,3,17]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgae687","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,4]]},"published":{"date-parts":[[2024,10,3]]}}}